Gayatri bioorganics Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories & Participants) Regulations, 2018. The submission was made on 11.04.2026 for the quarter ended 31.03.2026.

Regulatory Compliance Details

The compliance certificate was submitted under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. Sreedhara Reddy Kanaparthy, Whole time Director with DIN 09608890, signed and submitted the certificate to BSE Limited at P. J. Towers, Dalal Street, Mumbai.

Dematerialization Process Certification

Venture Capital and Corporate Investments Private Limited, acting as the registrar and transfer agent, issued the compliance certificate on 03.04.2026. The certificate confirms adherence to prescribed dematerialization procedures and regulatory timelines.

The certification covers several key compliance areas:

• Securities received for dematerialization have been mutilated and cancelled after due verification
• Depositories have been updated as registered owners within the mandated 15-day period
• Details of securities have been furnished to relevant stock exchanges
• Both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) records have been updated

Corporate Information

Gayatri Bioorganics Limited operates from its registered and corporate office located at B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad 500082, Telangana. The company holds CIN L24110TG1991PLC013512 and maintains its securities listing with BSE Limited under scrip code 524564.

Gayatri bioorganics Limited has announced a board meeting scheduled for April 15, 2026, to deliberate on significant corporate restructuring matters. The meeting will be held at the company's registered office in accordance with regulatory requirements.

Board Meeting Agenda

The board meeting has been convened under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda items include:

Trading Window Restrictions

The company has implemented trading restrictions in compliance with insider trading regulations. The trading window for dealing in the company's securities has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31, 2026.

These restrictions apply to:

• All designated persons
• Their immediate relatives
• All connected persons covered under the company's Code of Conduct

The closure is in accordance with the company's Code for regulating, monitoring and reporting of trading by insiders, framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Corporate Information

The notification was signed by Sreedhara Reddy Kanaparthy, Whole-time Director (DIN: 09608890), on April 8, 2026. The company is headquartered at TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad, Telangana, and operates under CIN L24110TG1991PLC013512.

This development represents a significant corporate action that requires board approval and regulatory compliance, with the scheme of reduction of share capital being the primary focus of the upcoming meeting.